- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Probing the Cause of Psoriasis
14 September 2005 (All day)
Is psoriasis a skin disease or an immune system disorder? The answer--key to developing an effective therapy--has remained elusive. Now genetic evidence indicates that psoriasis begins as a skin disorder that can also trigger an immune system response.
Psoriasis, a noncontagious, lifelong disease characterized by skin lesions, red patches, white blisters, and sometimes arthritic inflammation, afflicts about 4.5 million adults in the United States. Researchers have been of two minds about the cause. One theory argues that it progresses from a haywire immune system response, signaled by elevated T-cells found in psoriatic lesions. But the disease may also be a genetic skin disorder, a theory supported by observed mutations in skin cell DNA. That skin disorder may then trigger an immune system response.
To gain better insight, researchers led by molecular pathologist Erwin Wagner of the Research Institute of Molecular Pathology in Vienna, Austria, set out to induce human psoriasislike symptoms in mice. They found they could do this by inhibiting two genes: JunB and c-Jun, both known to regulate cell proliferation and mutations. This pointed strongly to a genetic trigger for the disease.
Then, to examine what role the immune system plays in psoriasis, the researchers inhibited T-cell response in the genetically deficient mice. They found that although the animals' arthritic inflammations and associated bone destruction largely disappeared, the skin lesions were still present, though milder. The researchers saw a similar response when they blocked another immune system trigger thought to be associated with the disease, TNF-alpha.
Overall, the findings suggest that psoriasis is fundamentally a skin disorder, though the immune system's T cells and TNF-alpha exacerbate the disease's inflammatory symptoms, the team reports 15 September in Nature. Though the study reinforces the idea that skin cells are more than passive "brick-and-mortar" walls shielding against disease, there is likely to be a complicated interplay of triggers between the immune system and mutated skin cells, notes immunologist Brian Nickoloff of Loyola University of Chicago Medical Center. However, he adds, the study makes an important clinical contribution by helping to identify new therapeutic targets.